A detailed history of Benjamin Edwards Inc transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Benjamin Edwards Inc holds 75 shares of LH stock, worth $14,951. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75
Holding current value
$14,951
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$209.01 - $232.56 $15,675 - $17,442
75 New
75 $16,000
Q3 2022

Oct 28, 2022

SELL
$204.81 - $262.19 $9,830 - $12,585
-48 Reduced 64.86%
26 $5,000
Q2 2022

Aug 12, 2022

SELL
$213.86 - $277.87 $25,877 - $33,622
-121 Reduced 62.05%
74 $17,000
Q1 2022

May 04, 2022

SELL
$259.82 - $298.18 $10,912 - $12,523
-42 Reduced 17.72%
195 $51,000
Q4 2021

Feb 07, 2022

BUY
$271.6 - $314.21 $64,369 - $74,467
237 New
237 $74,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $17.9B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.